International Biotechnology Trust’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

International Biotechnology Trust’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-27,000	Closed	-$970K	–	56
2020 Q2	$970K	Hold	27,000	–	–	0.32%	43
2020 Q1	$734K	Sell	27,000 -53,000	-66%	-$1.48M	0.33%	42
2019 Q4	$1.57M	Hold	80,000	–	–	0.57%	38
2019 Q3	$1.04M	Hold	80,000	–	–	0.48%	41
2019 Q2	$997K	Buy	80,000 +25,420	+47%	+$338K	0.37%	51
2019 Q1	$792K	Buy	+54,580	New	+$697K	0.29%	57

Other funds holding MNTA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return

International Biotechnology Trust's MNTA Position: Q3 2020 in Review

International Biotechnology Trust sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q3 2020, closing a stake of 27,000 shares — an estimated $970K sold.

International Biotechnology Trust first reported a position in MNTA in Q1 2019 and held it in 6 quarters. The position peaked at $1.57M in Q4 2019. 211 funds tracked by Wall St. Rank hold MNTA as of Q3 2020.

International Biotechnology Trust reported no remaining Momenta Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
International Biotechnology Trust sold 27,000 Momenta Pharmaceuticals, Inc. shares in Q3 2020, an estimated $970K.
International Biotechnology Trust first reported a position in Momenta Pharmaceuticals, Inc. in Q1 2019 and held it in 6 quarters.
International Biotechnology Trust's Momenta Pharmaceuticals, Inc. position peaked at $1.57M in Q4 2019.
211 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q3 2020.

Based on International Biotechnology Trust's 13F filing for Q3 2020, filed 1 Dec 2020.